Clinical Trials Logo

Filter by:
  • None
  • Page 1
NCT ID: NCT02372006 Recruiting - Rhabdomyosarcoma Clinical Trials

Phase I Trial of Afatinib in Pediatric Tumours

Start date: April 29, 2015
Phase: Phase 1
Study type: Interventional

Open-label, dose escalation, monotherapy, basket trial with biomarker specific MTD expansion cohort The trial will consist of 2 parts: 1. Dose finding part to determine the MTD 2. Biomarker specific MTD expansion cohort to assess clinical anti-tumour activity in included tumour types